Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Family-Supported Smoking Cessation for Chronically Ill Veterans
This study is currently recruiting participants.
Verified by Department of Veterans Affairs, November 2008
Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00448344
  Purpose

The overarching aim of the study is to evaluate in a randomized trial the impact of a family-supported intervention compared to a standard veteran-focused telephone counseling control group to promote smoking cessation among cancer and heart disease patients.


Condition Intervention
Chronic Disease
Neoplasm
Cardiovascular Disease
Behavioral: Family-supported
Behavioral: Standard Telephone counseling

MedlinePlus related topics: Cancer Coping with Chronic Illness Quitting Smoking Smoking
Drug Information available for: Nicotine polacrilex Nicotine tartrate
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Family-Supported Smoking Cessation for Chronically Ill Veterans

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • The impact of a family-supported intervention on rates of abstinence from cigarettes (self-reported 7-day point prevalent abstinence) at 2 weeks and 12-months post-treatment follow-ups. [ Time Frame: 2 weeks and 12-months post-treatment follow-ups ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The impact of a family-supported intervention on perceived support for quitting and on quality of life in veterans at 2 weeks and 12-months post-treatment follow-ups. [ Time Frame: 2 weeks and 12-months post-treatment follow-ups ] [ Designated as safety issue: No ]

Estimated Enrollment: 470
Study Start Date: February 2008
Estimated Study Completion Date: January 2011
Estimated Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Family-supported smoking cessation
Behavioral: Family-supported
Group receives quit kit, option for nicotine replacement therapy, and 5 telephone counseling sessions with the goal of attaining social support during the process of quitting smoking
2
Standard smoking cessation
Behavioral: Standard Telephone counseling
Group receives quit kit, option for nicotine replacement therapy, and 5 standard smoking cessation telephone counseling sessions

Detailed Description:

ANTICIPATED IMPACT(S) ON VETERAN'S HEALTHCARE:

Veterans with chronic disease who continue to smoke exact a significant burden on the VA health care system. Effective smoking cessation programs, that target veterans who continue to smoke after the diagnosis of a smoking-related chronic illness, are needed.

BACKGROUND/RATIONALE:

Chronic diseases related to tobacco exposure are common among veterans. Persistent tobacco use after being diagnosed with these diseases decreases quality of life and survival. Yet, 30% of veterans with these conditions continue to smoke. Researchers have found that the social environment is important for smokers. In our current NCI-funded study, 70% of veterans with lung cancer identified at least one family member who smokes and 45% live with a family member that smokes. A family-supported smoking cessation intervention timed to follow a veteran's diagnosis of cancer or heart disease could be effective for helping veterans quit smoking.

OBJECTIVES:

The overarching aim of the study is to evaluate in a randomized trial the impact of a family-supported intervention compared to a standard veteran-focused telephone counseling control group to promote smoking cessation among cancer and heart disease patients.

AIM 1: To evaluate the impact of a family-supported intervention on rates of abstinence from cigarettes (self-reported 7-day point prevalent abstinence) at 2 weeks, and 12-month post-treatment follow-ups.

Hypothesis 1: Abstinence rates will be significantly higher among veterans who receive the family-supported intervention than those who receive the standard telephone counseling control.

AIM 2: To evaluate the impact of a family-supported intervention on perceived support for quitting 2 weeks and 12-month post-treatment follow-ups.

Hypothesis 2: Perceived support for quitting smoking will be significantly greater among veterans who receive the family-supported intervention than those who receive the standard telephone counseling control.

AIM 3: To measure the impact of a family-supported intervention on quality of life in veterans 2 weeks, and 12-month post-treatment follow-ups.

Hypothesis 3: Symptom-related quality of life will be significantly greater among veterans who receive the family-supported intervention than those who receive the standard telephone counseling control.

METHODS: Proposed is a two-group design in which 470 veterans who smoke will be randomized to receive:

STANDARD TELEPHONE COUNSELING control including a letter from a VA physician encouraging the patient to quit smoking, nicotine replacement (if not contraindicated), a self-help cessation kit, and 5 standard telephone counseling calls; or FAMILY-SUPPORTED intervention that includes all components of the control arm plus a Family-supported intervention that includes a support skills booklet and an additional telephone counseling protocol focusing on social support. .

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Enrolled in the Durham VA for ongoing care
  • Seen at a DVAMC clinic for care of cancer or cardiovascular disease within the previous 3 months
  • Current smokers and planning to quit smoking in the next 30 days

Exclusion Criteria:

  • Active diagnosis of psychosis documented in medical record
  • Does not have access to a telephone
  • Refusal to provide informed consent
  • Severely impaired hearing or speech
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00448344

Contacts
Contact: Lesley Rohrer (919) 668-0305 lesley.rohrer@va.gov
Contact: Lori Bastian, MD MPH (919) 286-6936 Lori.Bastian@va.gov

Locations
United States, North Carolina
VA Medical Center Recruiting
Durham, North Carolina, United States, 27705
Contact: Kathy L Weatherspoon     919-286-6936     Kathy.weatherspoon@va.gov    
Contact: Susan B Armstrong     (919) 286-6936     beth.armstrong@med.va.gov    
Sub-Investigator: Hayden B. Bosworth, PhD            
Principal Investigator: Lori Bastian, MD MPH            
Sponsors and Collaborators
Investigators
Principal Investigator: Lori Bastian, MD MPH Department of Veterans Affairs
  More Information

Responsible Party: Department of Veterans Affairs ( Bastian, Lori - Principal Investigator )
Study ID Numbers: IIR 05-202
Study First Received: March 14, 2007
Last Updated: November 20, 2008
ClinicalTrials.gov Identifier: NCT00448344  
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
veterans
smoking cessation

Study placed in the following topic categories:
Nicotine polacrilex
Smoking
Nicotine
Chronic Disease

Additional relevant MeSH terms:
Disease Attributes
Neoplasms
Pathologic Processes
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 14, 2009